Research programme: radiopharmaceuticals cancer therapeutics - InhibRx Biosciences
Alternative Names: 225Ac radioisotopeLatest Information Update: 06 Jun 2024
At a glance
- Originator Inhibrx
- Class Antineoplastics; Radiopharmaceuticals
- Mechanism of Action Ionising radiation emitters
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Research Cancer